Saturday 17 October 2026
Export CCM’s income statement to Excel — free account
Concord Medical Services Holdings Limited
CCM Healthcare Medical Care Facilities
Concord Medical Services Holdings Limited’s revenue for fiscal 2025 (year ended December 2025) was $65.9 million, up 25.2% from fiscal 2024.
3.63
0.08
−2.16%
Follow CCM
| Jun '25 | Jun '24 | Jun '23 | Dec '22 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
— | — | 2.49 | 3.52 | |
P/FCF ratio |
— | — | 5.75 | 7.54 | |
P/Operating CF |
— | — | 4.92 | 6.44 | |
P/B ratio |
— | — | 1.35 | 0.00 | |
Price to Tangible BV |
— | — | 2.40 | 0.00 | |
EV/Sales |
— | — | 4.74 | 6.57 | |
EV/EBITDA |
— | — | 0.00 | 0.00 | |
EV/Operating CF |
— | — | 5.41 | 6.96 | |
EV/FCF |
— | — | 10.92 | 14.05 | |
Quick Ratio |
0.10 | 0.19 | 0.27 | 0.26 | |
Current Ratio |
0.42 | 0.47 | 0.64 | 0.68 | |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
Debt/Assets |
45.01% | 45.38% | 46.09% | 53.21% | |
Debt/Equity |
1.76 | 1.56 | 1.34 | (1.73) | |
Asset Turnover |
0.00 | 0.00 | 0.18 | 0.17 | |
Operating CF/Net income |
— | — | 0.00 | 0.00 | |
Interest Coverage |
— | — | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
— | — | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
— | — | 62.07% | 65.82% | |
Intangible Assets out of Total Assets |
0.13 | 0.13 | 0.15 | 0.15 | |
Share Based Compensation of Revenue |
— | — | 0.00% | 0.00% | |
Graham Net Nets |
— | — | (1.11) | (0.93) | |
Graham Number |
— | — | 0.00 | 13.85 | |
Earnings Yield |
— | — | (6.38%) | (4.89%) | |
Free Cash Flow Yield |
— | — | 17.39% | 13.27% | |
Revenue per Share |
— | — | 1.46 | 1.68 | |
Operating CF per Share |
— | — | 0.00 | 0.00 | |
Capex per Share |
— | — | 0.00 | 0.00 | |
Free Cash Flow per Share |
— | — | 0.00 | 0.00 | |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/EBIT |
— | — | 0.00 | 0.00 | |
Capex to Sales |
— | — | 0.00 | 0.00 | |
Price to Operating Income |
— | — | 0.00 | 0.00 | |
| Other line items | |||||
Working Capital |
(199.48) | (157.26) | (66.89) | (51.99) | |
Net Current Asset Value |
(556.44) | (505.34) | (431.82) | (471.29) | |
Average Receivables |
10.94 | 15.63 | 13.71 | 25.21 | |
Average Payables |
15.88 | 16.80 | 9.69 | 11.98 | |
Average Inventory |
6.17 | 5.73 | 6.10 | 12.44 | |
Average Assets |
941.35 | 948.11 | 886.24 | 847.25 | |
Average Common Equity |
5.56 | 24.67 | 70.06 | (184.75) |
Columns are period end dates